home / stock / exas / exas news


EXAS News and Press, Exact Sciences Corporation

Stock Information

Company Name: Exact Sciences Corporation
Stock Symbol: EXAS
Market: NASDAQ
Website: exactsciences.com

Menu

Get EXAS Alerts

News, Short Squeeze, Breakout and More Instantly...

EXAS - Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced it has earned the 2026 Gallup Exceptional Workplace Award (GEWA), marking the third consecutive year the company has received this prestigious recognition. The award honors organizati...

EXAS - Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration

Amalgam Rx, Inc., Privia Health, and Exact Sciences Corp. highlight how coordinated, EHR-enabled patient outreach supported measurable screening impact at scale. Amalgam Rx, Inc ., a leader in data-driven, AI-powered healthcare engagement and clinical decision support, today annou...

EXAS - Forget Tilray: This Steady Income Stock Beats Wild Cannabis Swings Every Time

2026-02-25 09:40:00 ET Tilray Brands (NASDAQ: TLRY) , like many other cannabis stocks, has taken investors on a wild roller-coaster ride the past few years, though for the most part, that ride has been downward. The stock soared by more than 10 times in the months after its 2018...

EXAS - Abbott eyes $20B bond sale to fund purchase of Exact Sciences - report

2026-02-23 11:10:57 ET More on Abbott Laboratories, Exact Sciences Abbott: Long-Term Investment Opportunity For Dividend Growth Investors Abbott Laboratories: Double-Digit Earnings Growth Makes It A Buy Abbott Laboratories: The Market's Overreaction Is The Long-Term ...

EXAS - Exact Sciences shareholders approve acquisition by Abbott

2026-02-20 16:17:26 ET More on Exact Sciences Exact Sciences: Abbott Acquisition A Positive Sign For Oncology Diagnostics Exact Sciences ticks higher amid reports HSR for Abbott deal expired CyberArk/Palo Alto Networks, Dayforce/Thoma Bravo among good bets for deal c...

EXAS - Exact Sciences Stockholders Approve Acquisition by Abbott

Exact Sciences Corporation (NASDAQ: EXAS) (“Exact Sciences”), a leading provider of cancer screening and diagnostic tests, today announced that its stockholders voted to approve the proposed acquisition of Exact Sciences by Abbott (NYSE: ABT) at the special meeting of stockholders h...

EXAS - Tudor Investment adds Alphabet, exits Meta, boosts iShares Core S&P 500 ETF, among Q4 trades

2026-02-18 10:48:02 ET More on Alphabet, Meta, etc. The Next Sector That Could Be Cannibalized By AI This Is When The Bull Market Is In Trouble S&P 500: The Path To 5,000 Is Getting Clearer Google takes wraps off budget Pixel 10a ahead of near imminent iP...

EXAS - Quant ratings on Soros Fund Management's top holdings: AMZN, GOOGL, TSM, NVDA

2026-02-16 12:13:38 ET More on Micron: Nothing Is Over Sumco Corporation (SUOPY) Q4 2025 Earnings Call Transcript Ashmore Group Plc (AJMPF) Q2 2026 Earnings Call Transcript U.S. dollar edges higher as mixed data, policy outlook keep gains in check: Currency R...

EXAS - Baron Discovery Fund Q4 2025: Winners, Laggards, Buys & Sells

2026-02-15 18:08:00 ET The following segment was excerpted from the Baron Discovery Fund Q4 2025 Shareholder Letter. ... Read the full article on Seeking Alpha For further details see: Baron Discovery Fund Q4 2025: Winners, Laggards, Buys &am...

EXAS - Soros Fund ups stake in Microsoft, NVIDIA, Apple as part of Q4 moves

2026-02-13 18:00:09 ET Hungarian-American investor George Soros's Soros Fund increased its stake in Microsoft ( MSFT ), NVIDIA ( NVDA ), and Apple ( AAPL ) as part of its Q4 portfolio positioning changes.... Read the full article on Seek...

Next 10